SageGuard Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.88M Buy
19,387
+688
+4% +$148K 0.69% 49
2026
Q1
$4.07M Buy
18,699
+4,143
+28% +$919K 0.63% 47
2025
Q4
$3.33M Buy
+14,556
New +$3.32M 0.53% 44
2021
Q3
Sell
-2,347
Closed -$264K 18
2021
Q2
$264K Buy
2,347
+151
+7% +$17K 0.12% 108
2021
Q1
$239K Buy
+2,196
New +$235K 0.11% 118

Other funds holding ABBV

SageGuard Financial Group's ABBV Position: Q2 2026 in Review

SageGuard Financial Group increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $148K and bringing the position to 19,387 shares worth $4.88M. The position accounts for 0.69% of the portfolio, ranked #49.

SageGuard Financial Group first reported a position in ABBV in Q1 2021 and has held it in 5 quarters since. 2,823 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SageGuard Financial Group held 19,387 shares of AbbVie worth $4.88M as of Q2 2026.
  • SageGuard Financial Group bought 688 AbbVie shares in Q2 2026, an estimated $148K.
  • AbbVie made up 0.69% of SageGuard Financial Group's portfolio in Q2 2026, its #49 holding.
  • SageGuard Financial Group first reported a position in AbbVie in Q1 2021 and has held it in 5 quarters since.
  • 2,823 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SageGuard Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.